Treatment of Smoking Lapses and Relapses

PHASE4CompletedINTERVENTIONAL
Enrollment

701

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Smoking Cessation
Interventions
DRUG

nicotine patch, experimental use

nicotine patch-transdermal, continue during lapses Nicotine patches are used according to normal package label, except if the participant lapses and smokes, they will continue to use the patch.

DRUG

nicotine patch, labeled use

nicotine patch-transdermal, discontinue during lapses Participants will use the nicotine patch while abstinent, but will remove the patch if there is a lapse and smoking resumes. This is the use indicated on current FDA approved labeling.

Trial Locations (1)

05401

University of Vermont, Burlington

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Vermont

OTHER

NCT01807871 - Treatment of Smoking Lapses and Relapses | Biotech Hunter | Biotech Hunter